219 related articles for article (PubMed ID: 35157527)
1. High dietary salt intake increases urinary NGAL excretion and creatinine clearance in healthy young adults.
Barnett AM; Babcock MC; Watso JC; Migdal KU; Gutiérrez OM; Farquhar WB; Robinson AT
Am J Physiol Renal Physiol; 2022 Apr; 322(4):F392-F402. PubMed ID: 35157527
[TBL] [Abstract][Full Text] [Related]
2. Effect of 0.9% NaCl compared to plasma-lyte on biomarkers of kidney injury, sodium excretion and tubular transport proteins in patients undergoing primary uncemented hip replacement - a randomized trial.
Østergaard AM; Jørgensen AN; Bøvling S; Ekeløf NP; Mose FH; Bech JN
BMC Nephrol; 2021 Mar; 22(1):111. PubMed ID: 33771116
[TBL] [Abstract][Full Text] [Related]
3. Sodium Bicarbonate Supplementation and Urinary TGF-
Raphael KL; Greene T; Wei G; Bullshoe T; Tuttle K; Cheung AK; Beddhu S
Clin J Am Soc Nephrol; 2020 Feb; 15(2):200-208. PubMed ID: 31974286
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of urinary neutrophil gelatinase-associated lipocalin and urinary kidney injury molecule-1 as biomarkers of renal function in cancer patients treated with cisplatin.
Ghadrdan E; Ebrahimpour S; Sadighi S; Chaibakhsh S; Jahangard-Rafsanjani Z
J Oncol Pharm Pract; 2020 Oct; 26(7):1643-1649. PubMed ID: 32046578
[TBL] [Abstract][Full Text] [Related]
5. Effect of 3% saline and furosemide on biomarkers of kidney injury and renal tubular function and GFR in healthy subjects - a randomized controlled trial.
Mose FH; Jörgensen AN; Vrist MH; Ekelöf NP; Pedersen EB; Bech JN
BMC Nephrol; 2019 Jun; 20(1):200. PubMed ID: 31159750
[TBL] [Abstract][Full Text] [Related]
6. Dietary sodium restriction decreases urinary NGAL in older adults with moderately elevated systolic blood pressure free from chronic kidney disease.
Wang W; Chonchol M; Seals DR; Nowak KL
J Investig Med; 2020 Oct; 68(7):1271-1275. PubMed ID: 32699180
[TBL] [Abstract][Full Text] [Related]
7. Urinary beta-2 microglobulin increases whereas TIMP-2 and IGFBP7 decline after unilateral nephrectomy in healthy kidney donors.
de Rooij ENM; Hoogeveen EK; Romijn FPHTM; van der Kooy SW; Veighey KV; Dekker FW; van Kooten C; Cobbaert CM; de Fijter JW
Sci Rep; 2024 Jun; 14(1):12901. PubMed ID: 38839764
[TBL] [Abstract][Full Text] [Related]
8. Urinary calprotectin, kidney injury molecule-1, and neutrophil gelatinase-associated lipocalin for the prediction of adverse outcome in pediatric acute kidney injury.
Westhoff JH; Seibert FS; Waldherr S; Bauer F; Tönshoff B; Fichtner A; Westhoff TH
Eur J Pediatr; 2017 Jun; 176(6):745-755. PubMed ID: 28409285
[TBL] [Abstract][Full Text] [Related]
9. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy.
Peters HP; Waanders F; Meijer E; van den Brand J; Steenbergen EJ; van Goor H; Wetzels JF
Nephrol Dial Transplant; 2011 Nov; 26(11):3581-8. PubMed ID: 21467131
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) as predictors of incident CKD stage 3: the Atherosclerosis Risk in Communities (ARIC) Study.
Bhavsar NA; Köttgen A; Coresh J; Astor BC
Am J Kidney Dis; 2012 Aug; 60(2):233-40. PubMed ID: 22542304
[TBL] [Abstract][Full Text] [Related]
11. Urine NGAL and KIM-1: tubular injury markers in acute lymphoblastic leukemia survivors.
Latoch E; Konończuk K; Taranta-Janusz K; Muszyńska-Rosłan K; Szymczak E; Wasilewska A; Krawczuk-Rybak M
Cancer Chemother Pharmacol; 2020 Dec; 86(6):741-749. PubMed ID: 33052454
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic performance of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for acute kidney injury in an obstructive nephropathy patient.
Xue W; Xie Y; Wang Q; Xu W; Mou S; Ni Z
Nephrology (Carlton); 2014 Apr; 19(4):186-94. PubMed ID: 24165570
[TBL] [Abstract][Full Text] [Related]
13. Effect of renin-angiotensin-aldosterone system inhibition, dietary sodium restriction, and/or diuretics on urinary kidney injury molecule 1 excretion in nondiabetic proteinuric kidney disease: a post hoc analysis of a randomized controlled trial.
Waanders F; Vaidya VS; van Goor H; Leuvenink H; Damman K; Hamming I; Bonventre JV; Vogt L; Navis G
Am J Kidney Dis; 2009 Jan; 53(1):16-25. PubMed ID: 18823687
[TBL] [Abstract][Full Text] [Related]
14. Urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as indicators of tubular damage in normoalbuminuric patients with type 2 diabetes.
de Carvalho JA; Tatsch E; Hausen BS; Bollick YS; Moretto MB; Duarte T; Duarte MM; Londero SW; Premaor MO; Comim FV; Delanghe JR; Moresco RN
Clin Biochem; 2016 Feb; 49(3):232-6. PubMed ID: 26519090
[TBL] [Abstract][Full Text] [Related]
15. Urine KIM-1 as a Potential Biomarker of Acute Renal Injury After Circulatory Collapse in Children.
Assadi F; Sharbaf FG
Pediatr Emerg Care; 2019 Feb; 35(2):104-107. PubMed ID: 27741065
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers for Chronic Kidney Disease Associated with High Salt Intake.
Hosohata K
Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28973979
[TBL] [Abstract][Full Text] [Related]
17. Effect of long-term storage of urine samples on measurement of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL).
van de Vrie M; Deegens JK; van der Vlag J; Hilbrands LB
Am J Kidney Dis; 2014 Apr; 63(4):573-6. PubMed ID: 24268306
[TBL] [Abstract][Full Text] [Related]
18. Estimated glomerular filtration rate and urine biomarkers in patients with single-ventricle Fontan circulation.
Opotowsky AR; Baraona FR; Mc Causland FR; Loukas B; Landzberg E; Landzberg MJ; Sabbisetti V; Waikar SS
Heart; 2017 Mar; 103(6):434-442. PubMed ID: 27670967
[TBL] [Abstract][Full Text] [Related]
19. Performance of urinary kidney injury molecule-1, neutrophil gelatinase-associated lipocalin, and N-acetyl-β-D-glucosaminidase to predict chronic kidney disease progression and adverse outcomes.
Lobato GR; Lobato MR; Thomé FS; Veronese FV
Braz J Med Biol Res; 2017 Mar; 50(5):e6106. PubMed ID: 28380198
[TBL] [Abstract][Full Text] [Related]
20. Acute high-dose MitoQ does not increase urinary kidney injury markers in healthy adults: a randomized crossover trial.
Linder BA; Stute NL; Hutchison ZJ; Barnett AM; Tharpe MA; Kavazis AN; Kirkman DL; Gutierrez OM; Robinson AT
Am J Physiol Renal Physiol; 2024 Jan; 326(1):F135-F142. PubMed ID: 37942539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
